Novimmune Competitors and Similar CompaniesClear all
Novimmune's competitors and similar companies include Valneva and UCB.
 Novimmune Novimmune is a company that focuses on its bispecific technology to build a pipeline of multispecific antibodies under the brand Light Chain Bioscience. |  Valneva Valneva is a specialty vaccine company focused on the development and commercialization of prophylactic vaccines for infectious diseases. |  UCB UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions. | |
Founding Date | Founding Date 1998 | Founding Date 2013 | Founding Date 1928 |
Type | Type Private | Type Public | Type Public |
Tags | |||
Locations | Locations Plan-les-Ouates, CH HQ | Locations Brussels, BE HQ Melbourne, AU Vienna, AT Braine L'alleud, BE Braine L'alleud, BE Leuven, BE São Paulo, BR see more | |
Employees | Employees 80 | Employees 713 | Employees 9,052 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 482.5 m | Valuation ($) 34.3 b |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) €157.9m (FY, 2025) | Revenue (est.) €7.4b (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods €8.2m (FY, 2025) | Cost of goods €1.4b (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit €177.7m (FY, 2025) | Gross profit €7.2b (FY, 2025) |
Net income | Net income N/A | Net income (€115.2m) (FY, 2025) | Net income €1.6b (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised $ 239.1m | Total funding raised $ 51.7m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Valneva
HQ
Saint-Herblain, FR
Employees
713
Valneva is a specialty vaccine company focused on the development and commercialization of prophylactic vaccines for infectious diseases.
View companyUCB
HQ
Brussels, BE
Employees
9,052
UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions.
View company